OTO-413
/ Otonomy
- LARVOL DELTA
Home
Next
Prev
1 to 7
Of
7
Go to page
1
April 25, 2023
"When will clinical trials for oto-413 begin? Is crowdfunding bad for fundraising?"
(@ajisonso)
Clinical
October 27, 2022
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
(clinicaltrials.gov)
- P1/2 | N=110 | Completed | Sponsor: Otonomy, Inc. | Active, not recruiting ➔ Completed | N=70 ➔ 110 | Trial completion date: Jun 2022 ➔ Sep 2022 | Trial primary completion date: Jun 2022 ➔ Sep 2022
Enrollment change • Trial completion • Trial completion date • Trial primary completion date • Otorhinolaryngology
July 03, 2022
A neurotrophic approach to treating hearing loss: Translation from animal models to clinical proof-of-concept.
(PubMed, J Acoust Soc Am)
- "A phase 1/2 clinical trial with OTO-413 has provided initial proof-of-concept for improved speech-in-noise hearing performance in subjects with hearing loss. Key considerations for the design of this clinical study, including aspects of the speech-in-noise assessments, are discussed."
Journal • Preclinical • Otorhinolaryngology • BDNF
June 22, 2022
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
(clinicaltrials.gov)
- P1/2 | N=70 | Active, not recruiting | Sponsor: Otonomy, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Otorhinolaryngology
June 18, 2021
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
(clinicaltrials.gov)
- P1/2; N=70; Recruiting; Sponsor: Otonomy, Inc.; Active, not recruiting ➔ Recruiting; N=40 ➔ 70; Trial completion date: Oct 2020 ➔ Jun 2022; Trial primary completion date: Oct 2020 ➔ Jun 2022
Clinical • Enrollment change • Enrollment open • Trial completion date • Trial primary completion date • Otorhinolaryngology
September 14, 2020
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
(clinicaltrials.gov)
- P1/2; N=40; Active, not recruiting; Sponsor: Otonomy, Inc.; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Otorhinolaryngology
June 17, 2020
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
(clinicaltrials.gov)
- P1/2; N=40; Recruiting; Sponsor: Otonomy, Inc.; N=30 ➔ 40
Clinical • Enrollment change
1 to 7
Of
7
Go to page
1